Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-21

Clinical Trial Update: Lamotrigine and Bupropion for Meniere's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lamotrigine and bupropion for Menière's disease is in progress, status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)
  • bupropion (bupropion)

Snippet

Sponsor: Dent Neuroscience Research Center | Conditions: Meniere Disease, Ménière's Vertigo | Phase 2 | Status: UNKNOWN